Guangxi Liuzhou Pharm Co Ltd Tangible Net Worth Ratio
Guangxi Liuzhou Pharm Co Ltd tangible net worth ratio. Guangxi Liuzhou Pharm Co Ltd (603368) has a Tangible Net Worth Ratio of 97.4% as of September 2025. This metric is calculated by deducting intangible assets (CN¥212.59 Million) from net assets (CN¥8.14 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 603368 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Guangxi Liuzhou Pharm Co Ltd (2011–2024)
Tangible net worth ratio of Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024. This chart shows how Guangxi Liuzhou Pharm Co Ltd's Tangible Net Worth Ratio has changed across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 97.4%, reflecting net assets of CN¥8.14 Billion with intangible assets of CN¥212.59 Million CNY. Check 603368 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Guangxi Liuzhou Pharm Co Ltd Tangible Net Worth Ratio by Year (2011–2024)
Guangxi Liuzhou Pharm Co Ltd tangible net worth ratio by year from 2011 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Guangxi Liuzhou Pharm Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Guangxi Liuzhou Pharm Co Ltd market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.2% | CN¥7.94 Billion | CN¥223.13 Million | CN¥21.27 Billion | ▲ +0.6 pp |
| 2023 | 96.6% | CN¥7.06 Billion | CN¥239.90 Million | CN¥20.16 Billion | ▲ +0.6 pp |
| 2022 | 96.0% | CN¥6.37 Billion | CN¥256.50 Million | CN¥18.61 Billion | ▼ -0.1 pp |
| 2021 | 96.1% | CN¥5.81 Billion | CN¥226.82 Million | CN¥15.87 Billion | ▼ -0.1 pp |
| 2020 | 96.2% | CN¥5.44 Billion | CN¥208.09 Million | CN¥14.81 Billion | ▲ +0.4 pp |
| 2019 | 95.8% | CN¥4.66 Billion | CN¥197.55 Million | CN¥11.96 Billion | ▼ -0.7 pp |
| 2018 | 96.5% | CN¥4.05 Billion | CN¥141.82 Million | CN¥9.77 Billion | ▼ -0.7 pp |
| 2017 | 97.2% | CN¥3.57 Billion | CN¥101.14 Million | CN¥7.55 Billion | ▲ +0.3 pp |
| 2016 | 96.8% | CN¥3.24 Billion | CN¥102.02 Million | CN¥6.28 Billion | ▲ +3.0 pp |
| 2015 | 93.8% | CN¥1.36 Billion | CN¥83.71 Million | CN¥4.30 Billion | ▼ -0.6 pp |
| 2014 | 94.5% | CN¥1.17 Billion | CN¥65.07 Million | CN¥3.74 Billion | ▲ +7.3 pp |
| 2013 | 87.2% | CN¥501.00 Million | CN¥64.18 Million | CN¥2.70 Billion | ▼ -1.5 pp |
| 2012 | 88.7% | CN¥378.59 Million | CN¥42.75 Million | CN¥2.03 Billion | ▲ +2.7 pp |
| 2011 | 86.0% | CN¥274.23 Million | CN¥38.47 Million | CN¥1.57 Billion | — |